Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Interferon regulatory factor 5 (IRF5); chemokine CXC motif ligand 1 (CXCL1; GRO; MGSA)

September 17, 2015 7:00 AM UTC

Mouse studies suggest inhibiting IRF5 could help treat inflammatory diseases. In a mouse model of antigen-induced arthritis, IRF5 knockout decreased knee swelling, synovial membrane thickening, synovi...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article